| Literature DB >> 35743772 |
Yu-Jhou Chen1,2, Chen-June Seak3,4,5, Hao-Tsai Cheng1,2,5,6, Chien-Cheng Chen5,6,7, Tsung-Hsing Chen1,5, Chang-Mu Sung1,5, Chip-Jin Ng4,5, Shih-Ching Kang8, Ming-Yao Su2,5,9, Sen-Yung Hsieh1,5.
Abstract
BACKGROUND: Caustic ingestion has gained increasing attention worldwide. However, the insight into whether to use esophagogastroduodenoscopy (EGD) or computed tomography (CT) for first-line investigation remains controversial. This study aimed to evaluate a diagnostic and management algorithm that combines EGD and CT for rapid triage.Entities:
Keywords: algorithm; caustic ingestion; computed tomography; corrosive injury; endoscopy; esophagogastroduodenoscopy; flowchart; patient categorization; severity stratification; surgery
Year: 2022 PMID: 35743772 PMCID: PMC9225358 DOI: 10.3390/jpm12060989
Source DB: PubMed Journal: J Pers Med ISSN: 2075-4426
Figure 1Reported flowchart of patient categorization and management for caustic ingestion used in Linkou Chang Gung Memorial Hospital (CGMH). Abbreviations: CT, computed tomography; EGD, esophagogastroduodenoscopy; F/U, follow-up; GI, gastrointestinal; NPO, nulla per os (nothing by mouth); OPD, out-patient department; S/S, signs/symptoms; TPN, total parenteral nutrition.
Figure 2Enrollment diagram of the study population. Abbreviations: CGMH, Chang Gung Memorial Hospital; GI, gastrointestinal.
Comprehensive demographic profiles of each group of patients.
| Variable | Group A | Group B1 | Group B2 | Group C1 | Group C2 | Group C3 | Group D | Total |
|---|---|---|---|---|---|---|---|---|
| ( | ( | ( | ( | ( | ( | ( | ( | |
| Female | 2 (66.7) | 5 (62.5) | 1 (50.0) | 22 (52.4) | 7 (70.0) | 25 (64.1) | 25 (42.4) | 87 (53.4) |
| Age, year | 64 (nil) | 51 (37) | 55 (nil) | 48 (22) | 45 (13) | 55 (26) | 43 (28) | 50 (28) |
| Old (age ≥ 65) | 1 (33.3) | 3 (37.5) | 1 (50.0) | 8 (19.0) | 1 (10.0) | 15 (38.5) | 14 (23.7) | 43 (26.4) |
| Caustics substances | ||||||||
| Acid | 3 (100) | 4 (50.0) | 1 (50.0) | 19 (45.2) | 6 (60.0) | 23 (59.0) | 25 (42.4) | 81 (49.7) |
| Alkaline | 0 (0) | 4 (50.0) | 1 (50.0) | 19 (45.2) | 4 (40.0) | 13 (33.3) | 25 (42.4) | 66 (40.5) |
| Uncertain 1 | 0 (0) | 0 (0) | 0 (0) | 4 (9.5) | 0 (0) | 3 (7.7) | 9 (15.3) | 16 (9.8) |
| Strong caustics (pH < 2 or >12) | 3 (100) | 6 (75.0) | 1 (50.0) | 20 (57.1) | 5 (50.0) | 21 (63.6) | 14 (26.4) | 70 (42.9) |
| Strong acids (pH < 2) | 3 (100) | 4 (50.0) | 1 (50.0) | 11 (26.8) | 4 (40.0) | 15 (44.1) | 9 (15.8) | 47 (28.8) |
| Strong alkalis (pH > 12) | 0 (0) | 2 (25.0) | 0 (0) | 9 (22.0) | 1 (10.0) | 6 (15.4) | 5 (8.8) | 23 (14.1) |
| Ingested amount, mL | 150 (nil) | 250 (200) | 505 (nil) | 100 (175) | 50 (125) | 100 (200) | 50 (120) | 100 (183) |
| Amount ≥ 100 mL | 2 (66.7) | 5 (83.3) | 1 (50.0) | 17 (58.6) | 3 (42.9) | 17 (63.0) | 15 (34.1) | 60 (50.8) |
| Suicidal ingestion | 3 (100) | 8 (100) | 2 (100) | 32 (76.2) | 9 (90.0) | 34 (87.2) | 38 (64.4) | 126 (77.3) |
| EGD grades | ||||||||
| Esophagus ≥ 2b | nil | 7 (87.5) | 1 (50) | 21 (50.0) | 9 (90.0) | 17 (43.6) | 0 (0) | 55 (34.4) |
| Stomach ≥ 2b | nil | 8 (100) | 1 (50) | 23 (54.8) | 10 (100) | 29 (76.3) | 0 (0) | 71 (44.4) |
| Duodenum ≥ 2b | nil | 5 (62.5) | 1 (50) | 3 (7.7) | 5 (50.0) | 6 (16.7) | 0 (0) | 20 (12.5) |
| Incomplete EGD study | nil | 0 (0) | 0 (0) | 3 (7.1) | 0 (0) | 3 (7.7) | 0 (0) | 6 (3.8) |
| ETT + MV during EGD | nil | 5 (62.5) | 0 (0) | 8 (19.0) | 3 (30.0) | 8 (20.5) | 0 (0) | 24 (15.0) |
| CT grades | ||||||||
| Esophagus ≥ 3 | 3 (100) | 5 (62.5) | 0 (0) | nil | 8 (80.0) | 20 (51.3) | 0 (0) | 36 (53.7) |
| Stomach ≥ 3 | 3 (100) | 8 (100) | 1 (50.0) | nil | 9 (90.0) | 25 (64.1) | 0 (0) | 46 (68.7) |
| Duodenum ≥ 3 | 0 (0) | 3 (37.5) | 0 (0) | nil | 0 (0) | 2 (5.1) | 0 (0) | 5 (7.5) |
| Admission | 3 (100) | 8 (100) | 2 (100) | 42 (100) | 10 (100) | 39 (100) | 0 (100) | 104 (63.8) |
| Inpatient days | 16 (nil) | 31 (29) | 8 (nil) | 10 (10) | 16 (13) | 13 (18) | 0 (0) | 8 (16) |
| ICU admission | 3 (100) | 7 (87.5) | 0 (0) | 5 (11.9) | 7 (70) | 9 (23.1) | 0 (0) | 31 (19.0) |
| In-hospital mortality | 1 (33.3) | 1 (12.5) | 0 (0) | 1 (2.4) | 0 (0) | 0 (0) | 0 (0) | 3 (2.9) |
| Operation | 3 (100) | 8 (100) | 0 (0) | 0 (0) | 10 (100) | 0 (0) | 0 (0) | 21 (12.9) |
| Systemic complications | 3 (100) | 4 (50.0) | 0 (0) | 18 (42.9) | 6 (60.0) | 9 (23.1) | 0 (0) | 43 (26.4) |
| Aspiration injury | 2 (66.7) | 2 (25.0) | 0 (0) | 11 (26.2) | 2 (20.0) | 6 (15.4) | 0 (0) | 22 (13.5) |
| Respiratory failure | 2 (66.7) | 2 (25.0) | 0 (0) | 8 (19.0) | 1 (10.0) | 6 (15.4) | 0 (0) | 19 (11.7) |
| Hepatic injury | 1 (33.3) | 2 (25.0) | 0 (0) | 6 (14.3) | 3 (30.0) | 2 (5.1) | 0 (0) | 14 (8.6) |
| Renal injury | 0 (0) | 1 (12.5) | 0 (0) | 7 (16.7) | 2 (20.0) | 2 (5.1) | 0 (0) | 12 (7.4) |
| Septic shock | 1 (33.3) | 1 (12.5) | 0 (0) | 1 (2.4) | 0 (0) | 0 (0) | 0 (0) | 3 (1.8) |
| DIC | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (10.0) | 0 (0) | 0 (0) | 1 (0.6) |
| GI complications | 3 (100) | 5 (62.5) | 1 (50.0) | 16 (38.1) | 5 (50.0) | 16 (41.0) | 0 (0) | 49 (30.1) |
| Bleeding | 3 (100) | 4 (50.0) | 1 (50.0) | 8 (19.0) | 2 (20.0) | 7 (17.9) | 0 (0) | 25 (15.3) |
| Perforation | 3 (100) | 3 (37.5) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 6 (3.7) |
| Stricture formation | 1 (33.3) | 1 (12.5) | 0 (0) | 9 (21.4) | 2 (20.0) | 13 (33.3) | 0 (0) | 0 (0) |
| Delayed fistula formation | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 1 (10.0) | 0 (0) | 0 (0) | 1 (0.6) |
| Follow-up duration, months | 50.9 (nil) | 32.5 (69.8) | 31.2 (nil) | 13.0 (50.2) | 33.8 (34.0) | 15.4 (32.4) | 6.1 (26.3) | 12.8 (39.3) |
| All-cause mortality | 2 (66.7) | 1 (12.5) | 0 (0) | 4 (9.5) | 0 (0) | 3 (7.7) | 1 (1.7) | 11 (6.7) |
| Endoscopic dilation for stricture or obstruction | 1 (33.3) | 0 (0) | 0 (0) | 7 (16.7) | 1 (10.0) | 6 (15.4) | 0 (0) | 15 (9.2) |
| Operation for stricture or obstruction | 0 (0) | 1 (12.5) | 0 (0) | 3 (7.1) | 0 (0) | 6 (15.4) | 0 (0) | 10 (6.1) |
| Psychiatric comorbidities | 3 (100) | 7 (87.5) | 2 (100) | 35 (83.3) | 9 (90.0) | 33 (84.6) | 37 (62.7) | 126 (77.3) |
| Systemic comorbidities | ||||||||
| Hypertension | 1 (33.3) | 3 (37.5) | 0 (0) | 13 (31.0) | 0 (0) | 13 (33.3) | 11 (18.6) | 41 (25.2) |
| Diabetes mellitus | 0 (0) | 0 (0) | 0 (0) | 7 (16.7) | 2 (20.0) | 10 (25.6) | 2 (3.4) | 21 (12.9) |
| Cancer | 0 (0) | 1 (12.5) | 0 (0) | 2 (4.8) | 1 (10.0) | 5 (12.8) | 1 (1.7) | 10 (6.1) |
| Coronary artery disease | 0 (0) | 0 (0) | 0 (0) | 1 (2.4) | 1 (10.0) | 2 (5.1) | 2 (3.4) | 6 (3.7) |
The data of continuous variables were expressed as the median and interquartile range (IQR = Q3 − Q1), and those of categorical variables were presented as numbers with percentages. Abbreviations: CT, computed tomography; DIC, disseminated intravascular coagulation; EGD, esophagogastroduodenoscopy; ETT + MV, endotracheal tube with mechanical ventilation; GI, gastrointestinal; ICU, intensive care unit. 1 The exact pH of ingested substances was uncertain in 16 (9.8%) patients at triage, and they received initial management following our algorithm. They were thus still included to prevent selection bias.
Figure 3The most severe grade of each patient group estimated using EGD and CT.
Figure 4Overall survival of each patient group.
Demographic characteristics between group C1 (not receiving CT) and group C2/C3 (receiving CT).
| Variable | Group C1 ( | Group C2/C3 ( | |
|---|---|---|---|
| Female | 22 (52.4) | 32 (65.3) | 0.285 |
| Age, year | 48 (22) | 54 (26) | 0.188 |
| Strong caustics (pH < 2 or > 12) | 20 (57.1) | 26 (60.5) | 0.82 |
| Acid/Alkaline/Uncertain | 19 (45.2)/19 (45.2)/4 (9.5) | 29 (59.2)/17 (34.7)/3 (6.1) | 0.405 |
| Ingested amount ≥ 100 mL | 17 (58.6) | 20 (58.8) | >0.999 |
| Suicidal ingestion | 32 (76.2) | 43 (87.8) | 0.175 |
| Psychiatric comorbidity | 35 (83.3) | 42 (85.7) | 0.827 |
| EGD grades | 0.122 | ||
| 0/1 | 1 (2.4)/3 (7.1) | 1 (2.0)/3 (6.1) | |
| 2a/2b | 7 (16.7)/10 (23.8) | 5 (10.2)/3 (6.1) | |
| 3a/3b | 11 (26.2)/10 (23.8) | 20 (40.8)/17 (34.7) | |
| ETT + MV during EGD | 8 (19.0) | 11 (22.4) | 0.798 |
| Inpatient days | 10 (10) | 14 (16) | 0.297 |
| In-hospital mortality | 1 (2.4) | 0 (0) | 0.466 |
| Overall survival 1 | 38 (90.5) | 46 (93.9) | 0.545 |
| Systemic complications | 18 (42.9) | 15 (30.6) | 0.276 |
| Aspiration injury | 11 (26.2) | 8 (16.3) | 0.305 |
| Respiratory failure | 8 (19.0) | 7 (14.3) | 0.582 |
| Hepatic injury | 6 (14.3) | 5 (10.2) | 0.749 |
| Renal injury | 7 (16.7) | 4 (8.2) | 0.334 |
| Septic shock | 1 (2.4) | 0 (0) | 0.462 |
| DIC | 0 (0) | 1 (2.0) | >0.999 |
| GI complications | 16 (38.1) | 21 (42.9) | 0.674 |
| Bleeding | 8 (19.0) | 9 (18.4) | >0.999 |
| Perforation | 0 (0) | 0 (0) | – |
| Stricture formation | 9 (21.4) | 15 (30.6) | 0.35 |
| Endoscopic dilation for stricture | 7 (16.7) | 7 (14.3) | 0.779 |
Continuous variables are expressed as the median and interquartile range (IQR = Q3 – Q1), and categorical variables are presented as numbers with percentages. Abbreviations: CT, computed tomography; DIC, disseminated intravascular coagulation; EGD, esophagogastroduodenoscopy; ETT + MV, endotracheal tube with mechanical ventilation; GI, gastrointestinal; ICU, intensive care unit. 1 Survival is expressed as the rate at the endpoint of the follow-up period (March 2021). The p-values were calculated using log-rank tests.
Logistic regression models for patients in group C2 (requiring operation) and group C3 (not requiring operation).
| Covariate | Univariate | Multivariate | ||
|---|---|---|---|---|
| Unadjusted OR (95% CI) for Requiring Operation | Adjusted OR (95% CI) for Requiring Operation | |||
| Age (year) | 0.960 (0.919–1.003) | 0.069 | 0.970 (0.923–1.020) | 0.236 |
| EGD grade 1 | 8.556 (1.622–45.136) | 0.011 | 8.555 (1.559–46.942) | 0.013 |
| CT grade 1 | 2.250 (0.497–10.178) | 0.292 | 0.350 (0.028–4.360) | 0.415 |
1 The most severe grade among the esophagus, stomach, and duodenum under EGD/CT. Abbreviations: CI, confidence interval; CT, computed tomography; EGD, esophagogastroduodenoscopy; OR, odds ratio.
Figure 5Grades of esophagogastroduodenoscopy (EGD) and computed tomography (CT) in differentiating group C2 (requiring operation) and group C3 (not requiring operation). The “most severe EGD/CT grades” refers to the most severe grade among the esophagus, stomach, and duodenum in each patient under EGD (Zargar’s 0, 1, 2a, 2b, 3a, 3b) and CT (grades 1, 2, 3, 4), respectively. The “combination of EGD + CT grades” is calculated by EGD (Zargar’s 0, 0 point; Zargar’s 1, 1 point; Zargar’s 2a, 2 points; Zargar’s 2b, 3 points; Zargar’s 3a, 4 points; Zargar’s 3b, 5 points) plus CT (grade 1, 1 point; grade 2, 2 points; grade 3, 3 points; grade 4, 4 points). Hence, the “combination of EGD + CT grades” ranges from 1 to 9 points. Abbreviations: AUROC, area under the receiver operating characteristic curve; CI, confidence interval; CT, computed tomography; EGD, esophagogastroduodenoscopy.